A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: interference (63), involvement (272)

Bevacizumab (15) Carboplatin-Paclitaxel (21 day)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (15)-CARBOPLATIN (AUC5)-PACLITAXEL (21 day) Regimen • Cervix-Bevacizumab (15)-Carboplati
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Cervical-cancer/Bevacizumab-15-Carboplatin-Paclitaxel-21-day.pdf

Neratinib

Description
Chemotherapy Protocol Breast Cancer NERATINIB Regimen • Breast Cancer – Neratinib Indication • Neratinib for extended adjuvant therapy for hormone receptor positive HER2overexpressed early
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Neratinib.pdf

Annual-report-2017-18

Description
ANNUAL REPORT AND ACCOUNTS 2017/18 incorporating the quality account 2017/18 Presented to Parliament pursuant to Schedule 7, paragraph 25
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/annual-report-2017-181.pdf

Gemcitabine-Vinorelbine Ver1.1

Description
Chemotherapy Protocol LYMPHOMA GEMCITABINE-VINORELBINE Regimen Lymphoma – Gemcitabine-Vinorelbine Indication Relapsed or refractory Non-Hodgkin’s Lymphoma Relapsed or refractory Hodgkin
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Gemcitabine-Vinorelbine-Ver1.1.pdf

Testing for COVID-19 (maternity) - patient information

Description
We have given you this factsheet because we are offering you a test for COVID-19. We hope this factsheet will
Url
/Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Testing-for-COVID-19-maternity.pdf

Pertuzumab/Trastuzumab SC

Description
Chemotherapy Protocol BREAST CANCER Regimen Pertuzumab / Trastuzumab SC • Breast Cancer – Trastuzumab / Pertuzumab SC Indicatio
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/PertuzumabTrastuzumab-SC.pdf

Bevacizumab-Irinotecan Ver 1.1

Description
Chemotherapy Protocol COLORECTAL CANCER BEVACIZUMAB-IRINOTECAN This protocol may require funding Regimen Colorectal Cancer – Bevacizumab-Iri
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Bevacizumab-IrinotecanVer11.pdf

Bevacizumab-Fluorouracil-Folinic Acid-Oxaliplatin

Description
Chemotherapy Protocol COLORECTAL CANCER BEVACIZUMAB-FLUOROURACIL-FOLINIC ACID (Modified de Gramont)OXALIPLATIN This regimen may require funding
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Bevacizumab-Fluorouracil-FolinicAcid-Oxaliplatin.pdf

Bevacizumab-Fluorouracil-Folinic Acid-Irinotecan

Description
Chemotherapy Protocol COLORECTAL CANCER BEVACIZUMAB-FLUOROURACIL-FOLINIC ACID (Modified de Gramont)IRINOTECAN This regimen may require funding R
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Bevacizumab-Fluorouracil-FolinicAcid-Irinotecan.pdf

Bevacizumab-Capecitabine

Description
Chemotherapy Protocol COLORECTAL CANCER BEVACIZUMAB-CAPECITABINE This protocol may require funding Regimen • Colorectal Cancer– Bevacizumab-Cape
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Bevacizumab-Capecitabine.pdf
141 to 150 of 200
Previous … 13 14 15 16 17 … Next